Company
Headquarters: Aubagne, France
Employees: 10,409
CEO: Dr. Joachim Kreuzburg
€15.45 Billion
EUR as of July 1, 2024
US$16.59 Billion
Company | Market Cap (USD) |
---|---|
Intuitive | $154.23 B |
EssilorLuxottica SA | $98.99 B |
Becton, Dickinson and Company | $65.82 B |
Alcon Inc. | $43.72 B |
HOYA Corp | $42.76 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sartorius Stedim Biotech SA has the following listings and related stock indices.
Stock: Euronext: DIM wb_incandescent
Stock: FSX: 56S1 wb_incandescent